NCI’s Cancer Research Center Will Use BioFortis' Labmatrix Software | GenomeWeb

NEW YORK (GenomeWeb News) - BioFortis today said that the National Cancer Institute selected its Labmatrix software for use within the Center for Cancer Research.

 
CCR evaluated the software within the Neuro Oncology Branch.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.